NCT02990416 2016-12-13A-dmDT390-bisFv(UCHT1) Fusion Protein With Ionizing Radiation and Pembrolizumab for the Treatment of Stage IV MelanomaAngimmune LLCPhase 1/2 Unknown63 enrolled
NCT00611208 2016-11-29A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL)Angimmune LLCPhase 2 Completed32 enrolled